HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long term effectiveness of low dose mithramycin for Paget's disease of bone.

Abstract
Nineteen patients with Paget's disease of bone were studied 7 months to 5 years after therapy with mithramycin in a dose averaging 11.5 microgram/kg body weight daily for 10 days. Thirteen patients, including 3 with the longest followup intervals, remained free of pain. Objective measures of disease activity (serum alkaline phosphatase level and 99mtechnetium pyrophosphate bone scan) were less favorable. There was no evidence of long term toxicity.
AuthorsA S Russell, I M Chalmers, J S Percy, B C Lentle
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 22 Issue 3 Pg. 215-8 (Mar 1979) ISSN: 0004-3591 [Print] United States
PMID154331 (Publication Type: Journal Article)
Chemical References
  • Alkaline Phosphatase
  • Plicamycin
Topics
  • Aged
  • Alkaline Phosphatase (blood)
  • Bone and Bones (diagnostic imaging)
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Osteitis Deformans (diagnosis, diagnostic imaging, drug therapy)
  • Plicamycin (administration & dosage, adverse effects, therapeutic use)
  • Radionuclide Imaging
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: